Rhaeos
PrivateLast Round
Grant
Oct 9, 2023
Total Funding Raised
$15.84M
Company Overview
Rhaeos is a medical device company developing FlowSense, a noninvasive wearable sensor designed to monitor bodily fluid flow, initially for hydrocephalus patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhaeos Comparables
Compare Rhaeos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroDx Development | 91% | |
| Madison Scientific | 83% | |
| Kitea Health | 81% | |
Rhaeos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 9, 2023 | ||||
| Series A | Feb 16, 2023 | ||||
| Seed | Dec 23, 2021 | ||||
| Accelerator | Sep 27, 2021 | ||||
| Grant | Mar 1, 2021 | ||||
Grant | Oct 6, 2020 |
Key People
Founding team and executive leadership
Rhaeos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| NIH RADx | Grant, Accelerator |
| Creative Ventures | Series A, Seed |
| Lateral Capital | Series A, Seed |
| A1 Health Ventures | Grant |
| National Institute of Neurological Disorders and Stroke | Grant, Accelerator |
| Band of Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 9, 2023
$1.5M grant from A1 Health Ventures and NIH
- Dec 23, 2021
$2.2M round led by Creative Ventures and Lateral Capital.
Rhaeos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rhaeos's valuation, stock price, and market status.